Cynvenio Biosystems Lands $25,426,258 Series B Funding
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=9bdc22f6-2a12-4a3d-a355-d2e62c3c9329 - Date
6/5/2015 - Company Name
Cynvenio Biosystems - Mailing Address
2260 Townsgate Road Westlake Village, CA 91361 USA - Company Description
Cynvenio Biosystems, Inc. is a California biotech company dedicated to providing game-changing technology to improve the diagnosis and treatment of cancer patients. Cynvenio’s rare cell detection and mutational profiling applications include the LiquidBiopsy blood test for the early detection of cancer, and the selection of individual patient therapeutic solutions. - Website
http://www.cynvenio.com - Transaction Type
Venture Equity - Transaction Amount
$25,426,258 - Transaction Round
Series B - Proceeds Purposes
Proceeds will be used for working capital by the Company. Note Conversion and Series B Preferred Stock Agreement. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities. - M&A Terms
- Venture Investor
